Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
Phase 2 study of IMVT-1402 in adults with Chronic Inflammatory Demyelinating Polyneuropathy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC [Phase 4]
Phase 4 study evaluating adults with chronic inflammatory demyelinating polyneuropathy transitioning from intravenous immunoglobulin to subc…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
The document describes a pre-approval access program for subcutaneous efgartigimod in adults with chronic inflammatory demyelinating polyneu…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
A completed clinical trial investigating whether IgG level fluctuations after initial intravenous immunoglobulin treatment relate to subsequ…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy [EARLY_Phase 1]
This completed Phase 1 study evaluates the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
A Phase 2 proof-of-concept study of SAR445088 for chronic inflammatory demyelinating polyneuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Two Dose Levels of Privigen in Pediatric CIDP [Phase 4]
A Phase 4 pediatric CIDP trial evaluating two dose levels of Privigen (intravenous immunoglobulin) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) [Phase 2]
This clinical trial update reports on the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP. [NA]
A completed clinical trial comparing FEETME Soles and GAITRITE Walkway for evaluating gait disorders in chronic inflammatory demyelinating p…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
The Vanderbilt University Medical Center clinical trial evaluating cutaneous nerve demyelination for diagnosis and treatment of chronic infl…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Quantification of Nerve Stiffness in Neuropathies [NA]
A completed clinical trial update investigating quantification of nerve stiffness in inflammatory neuropathies including Chronic Inflammator…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of batoclimab in adults with active Chronic Inflammatory Demyelinating Po…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [NA]
The University of South Florida completed a clinical trial evaluating subcutaneous immunoglobulin for chronic inflammatory demyelinating pol…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of a subcutaneous formulation of efgartigimod in adults with Chronic Inflammatory Demyeli…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
A completed clinical trial evaluating electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneur…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 [Phase 1]
This first-in-human Phase 1 trial of PF-06755347 evaluating safety, tolerability, and pharmacokinetics was terminated, and results have been…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy [Phase 3]
Phase 3 trial of Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [NA]
A pediatric trial evaluating non-invasive vagus nerve stimulation (nVNS) for chronic inflammatory demyelinating polyneuropathy (CIDP) has be…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy [Phase 2]
A Phase 2 proof-of-concept trial evaluating rituximab in CIDP patients who did not respond to conventional immune therapy. Overall status is…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy [Phase 3]
Phase 3 trial evaluating three different dosages of NewGam for chronic inflammatory demyelinating polyneuropathy has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study [Phase 2]
Phase 2 open-label pilot study of MD1003 (serendem) in demyelinating neuropathies completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
Phase 2 trial evaluating lipoic acid for chronic inflammatory demyelinating polyneuropathy (CIDP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
Phase 2 clinical trial update on hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy has completed…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]
Phase 3 extension study evaluating maintenance subcutaneous immunoglobulin (IgPro20) in CIDP has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [Phase 3]
A Phase 3 study evaluating subcutaneous immunoglobulin IgPro20 for chronic inflammatory demyelinating polyneuropathy has completed and poste…